17/12/2017
Anapharm Bioanalytics has successfully developed and validated a bioanalytical method for determination of Unconjugated Estradiol and Estrone in human plasma by LC-MS/MS.
15/05/2017
We are pleased to announce that as part of our rebranding strategy, our brand name has now changed from Anapharm Europe to Anapharm Bioanalytics.
28/04/2016
Anapharm Europe is proud to announce that it has successfully undergone its first US FDA inspection at its Barcelona based bioanalytical lab.
03/03/2016
Anapharm Europe is proud to announce that it has recently renewed its ANVISA (Brazil) certificate.
16/04/2015
Anapharm Europe has renewed its certification to offer the advantages of the French research tax credit (crédit d’impôt recherche) for period 2015 – 2019.
19/01/2015
Anapharm Biotech, the peptide and protein chemistry division of Anapharm Europe, has completed method development of biomarkers Anti-IIa, Anti-Xa and TPFI in human plasma by chromogenic assays and ELISA, respectively.
15/11/2014
Anapharm Europe has improved the limit of quantification for analysis of Formoterol achieving a LLOQ of 0.2 pg/mL in Human Plasma.
02/09/2014
Anapharm Europe has renewed once more its Certificate for Good Laboratory Practice Principles (GLP).
04/04/2014
Anapharm Europe has renewed once more its Certificate for ANVISA (Brasil).